IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC)
Status:
Terminated
Trial end date:
2021-10-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of PF-06650833 in addition to
standard-of-care compared to standard-of-care treatment alone in improving outcomes in
patients with COVID-19.